58 results
Page 2 of 3
S-3ASR
83b o4oc4g4
26 Feb 21
Automatic shelf registration
12:00am
S-3ASR
bbbwtb6jpo9zhjgm1awj
26 Feb 21
Automatic shelf registration
12:00am
8-K
EX-1.1
54b9wq 6hppngdk42b9l
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
gxwl8d8
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
rsnjd4 7u6fy1
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K/A
EX-99.2
off1j540m
23 Nov 20
Consolidated Financial Statements
12:00am
424B7
5iw9i8a30zsz19 fj
5 Nov 20
Prospectus with selling stockholder info
5:27pm
8-K
EX-10.4
n51a3nmr1k304m606ql
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.3
u3wj9wgtupg893weu3rt
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
425
l8bu0vk4f5hcsvojppn
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-10.3
07o321 gneu
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-2.1
w81wa
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
S-3ASR
0bd0tyy
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
vls8wkj4czmyfy omo
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-1.1
0jdx u15nck8cd
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
cnvg5k5
3 Apr 20
Prospectus supplement for primary offering
12:00am